![Troy Ignelzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 416 700 $ in data 30/06/2026
Troy A. Ignelzi is currently Chairman at Vedanta Biosciences, Inc. since 2020.
He is an Independent Director at Abivax SA starting in 2023, at Contineum Therapeutics, Inc. starting in 2024, and at Harmony Biosciences Holdings, Inc. starting in 2026.
He is also Chief Financial Officer at Rapport Therapeutics, Inc. since 2023.
Formerly, Mr. Ignelzi was Independent Director at CinCor Pharma, Inc. from 2021 to 2023.
He served as Chief Financial Officer at Karuna Therapeutics, Inc. from 2019 to 2023 and as Chief Financial & Accounting Officer at scPharmaceuticals, Inc. from 2016 to 2019.
He was Chief Financial Officer at Juventas Therapeutics, Inc. from 2014 to 2016.
He held the position of Senior VP-Operations & Business Development at PharmaLex GmbH from 2013 to 2014.
He was Vice President-Business Development at Esperion Therapeutics, Inc. from 2009 to 2013 and VP-Business Development & Strategic Planning at InSys Therapeutics, Inc. from 2007 to 2009.
Mr. Ignelzi completed undergraduate studies at Ferris State University (Michigan).
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/04/2026 | 10.000 ( 0,02% ) | 416 700 $ | 30/06/2026 | |
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 02/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
ABIVAX SA -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ABIVAX | Direttore/Membro del Consiglio | 11/07/2023 |
| RAPPORT THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/11/2023 |
| CONTINEUM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 20/05/2024 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Direttore/Membro del Consiglio | 02/04/2026 |
| Società | Posizione | Fine |
|---|---|---|
| KARA THER | Direttore Finanziario/CFO | 29/09/2023 |
| CINCOR PHARMA, INC. | Direttore/Membro del Consiglio | 24/02/2023 |
| SCPHARMACEUTICALS INC. | Direttore Finanziario/CFO | 28/02/2019 |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Direttore Finanziario/CFO | 01/02/2016 |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Direttore operativo | 01/10/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Health Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
PharmaLex GmbH
PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Technology Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
